The opioid crisis in the United States and the strategies to address the epidemic

doi:10.5246/jcps.2023.02.010

Journal of Chinese Pharmaceutical Sciences ›› 2023, Vol. 32 ›› Issue (2): 122-129.DOI: 10.5246/jcps.2023.02.010

• Drug administration and clinical pharmacy column • Previous Articles Next Articles

The opioid crisis in the United States and the strategies to address the epidemic

Chang Wang¹^,⁴^,^#, Chen Jiang²^,^#, Jing Chen³^,^*(), Chengliang Zhang⁴^,^*()

1 Department of Pharmacy, Lanzhou University Second Hospital, Lanzhou 730030, China
2 Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States
3 Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
4 Department of Pharmacy, Tongji Hospital Affiliated with Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received:2022-10-16 Revised:2022-11-09 Accepted:2022-11-12 Online:2023-02-28 Published:2023-02-28
Contact: Jing Chen, Chengliang Zhang
About author:
# These authors contributed equally to this work.

Abstract

Abstract:

Opioids can alleviate pain and are the main drugs for clinical analgesic treatment. However, due to poor management or improper application, it may cause drug abuse, social harm, and even public health events. The United States has experienced three opioid crises in the past 20 years, which have not only adversely affected patients’ health, but also caused significant economic losses and resource waste to society. This paper reviewed the process of the three opioid crises in the United States, analyzed the causes, and summarized the strategies to address the national epidemic of opioids and the enlightenment of the opioid crisis on clinical work to provide references for the management and clinical use of opioids.

Key words: Opioid crisis, Drug abuse, Pain management

Supporting:

Chang Wang, Chen Jiang, Jing Chen, Chengliang Zhang. The opioid crisis in the United States and the strategies to address the epidemic[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 122-129.

Figures/Tables 1

References 27

[1]	Hedegaard, H.; Miniño, A.M.; Spencer, M.R.; Warner, M. Drug overdose deaths in the United States, 1999–2020. NCHS Data Brief, no 428. Hyattsville, MD: National Center for Health Statistics. 2021. This article can be found online at https://dx.doi.org/10.15620/cdc:112340.
[2]	Kolodny, A.; Courtwright, D.T.; Hwang, C.S.; Kreiner, P.; Eadie, J.L.; Clark, T.W.; Alexander, G.C. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu. Rev. Public Health. 2015, 36, 559–574.
[3]	Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers: United States, 1999: 2008. MMWR Morb. Mortal. Wkly Rep. 2011, 60, 1487–1492.
[4]	Centers for Disease Control and Prevention (CDC). Announcements: Release of Issue Brief: Unintentional Drug Poisoning in the United States. Mmwr Morb. Mortal. Wkly Rep. 2010, 59, 300.
[5]	Helmerhorst, G.; Teunis, T.; Janssen, S.; Ring, D. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? Bone Jt. J. 2017, 99-B, 856–864.
[6]	Rudd, R.A.; Paulozzi, L.J.; Bauer, M.J.; Burleson, R.W.; Carlson, R.E.; Dao, D.; Davis, J.W.; Dudek, J.; Eichler, B.A.; Fernandes, J.C.; Fondario, A. Increases in heroin overdose deaths—28 states, 2010 to 2012. MMWR Morb. Mortal. Wkly Rep. 2014, 63, 849.
[7]	Rudd, R.A.; Seth, P.; David, F.; Scholl, L. Increases in drug and opioid-involved overdose deaths - United States, 2010-2015. MMWR Morb. Mortal. Wkly Rep. 2016, 65, 1445–1452.
[8]	Li, J.; Xie, H.Z.; Deng, A. Reflections on drug regulation caused by the crisis of opioid drug abuse in the United States. Published 28 December. 2018.
[9]	Sun, W.J.; Breslin, T. A new trade war with an opium component: can the US opioids crisis Be solved by banning fentanyl in China? Iran. J. Public Health. 2021, 50, 2347–2348.
[10]	American Medical Association. Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic. 2020. This article can be found online at https://www.ama-assn.org/system/files/2020-12/issue-brief-increases-in-opioid-related-overdose.pdf.
[11]	Manchikanti, L.; Helm, S.; Fellows, B.; Janata, J.W.; Pampati, V.; Grider, J.S.; Boswell, M.V. Opioid epidemic in the United States. Pain Physician. 2012, 15, ES9–ES38.
[12]	Lyden, J.; Binswanger, I.A. The United States opioid epidemic. Semin. Perinatol. 2019, 43, 123–131.
[13]	Babu, K.M.; Brent, J.; Juurlink, D.N. Prevention of opioid overdose. N. Engl. J. Med. 2019, 380, 2246–2255.
[14]	Dowell, D.; Haegerich, T.M.; Chou, R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. MMWR Recomm. Rep. 2016, 65, 1–49.
[15]	Mir, H.R.; Miller, A.N.; Obremskey, W.T.; Jahangir, A.A.; Hsu, J.R. Confronting the opioid crisis: practical pain management and strategies: AOA 2018 critical issues symposium. J. Bone Joint Surg. Am. 2019, 101, e126.
[16]	Soelberg, C.D.; Brown, R.E.; Jr, Du Vivier, D.; Meyer, J.E.; Ramachandran, B.K. The US opioid crisis: current federal and state legal issues. Anesth. Analg. 2017, 125, 1675–1681.
[17]	Association Of State And Territorial Health Officials (ASTHO). Increasing Number of States Require Naloxone to be Co-Prescribed with Opioids. 2019. This article can be found online at https://www.astho.org/StatePublicHealth/Increasing-Number-of-States-Require-Naloxone-Co-Prescribed-with-Opioids/08-15-19/.
[18]	Wakeman, S.E.; Barnett, M.L. Primary care and the opioid-overdose crisis-buprenorphine myths and realities. N. Engl. J. Med. 2018, 379, 1–4.
[19]	Larochelle, M.R.; Bernson, D.; Land, T.; Stopka, T.J.; Wang, N.; Xuan, Z.; Bagley, S.M.; Liebschutz, J.M.; Walley, A.Y. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann. Intern. Med. 2018, 169, 137–145.
[20]	D’Onofrio, G.; McCormack, R.P.; Hawk, K. Emergency departments—a 24/7/365 option for combating the opioid crisis. N. Engl. J. Med. 2018, 379, 2487–2490.
[21]	Abramowitz, P. ASHP Opioid Task Force Focuses on Role of Pharmacists in Combating Opioid Crisis. 2019. This article can be found online at https://connect.ashp.org/blogs/paul-abramowitz/2019/09/30/ashp-opioid-task-force-focuses-on-role-of-pharmaci?ssopc=1.
[22]	American Society of Health-System Pharmacists (ASHP). Expand Pharmacists’ Ability to Treat Opioid Addiction. 2019. This article can be found online at https://www.ashp.org/advocacy-and-issues/whats-new/opioid-action.
[23]	Ling, W.; Mooney, L.J.; Hillhouse, M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Published. 2011.
[24]	Alam, A.; Gomes, T.; Zheng, H.; Mamdani, M.M.; Juurlink, D.N.; Bell, C.M. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch. Intern. Med. 2012, 172, 425–430.
[25]	Tobin, D.G.; Andrews, R.; Becker, W.C. Prescribing opioids in primary care: safely starting, monitoring, and stopping. Clevel. Clin. J. Med. 2016, 83, 207–215.
[26]	Yin, Y.F. Psychological assessment and nursing intervention on opioid dependence patients. China Health Stand. Manag. 2015, 6, 203–204.
[27]	Liu, D.; Li, G.H.; Zhao, R.S.; Li, L.; Dong, M.; Wu, Y.B.; Li, J.; Chen, C.Q.; Fang, W.T.; Gui, L.; Guo, J.H.; Hao, T.N.; Liu, J.Y.; Mao, R.H.; Qiu, T.T.; Ren, X.Y.; Shen, B.Y.; Teng, X.; Wu, G.J.; Yu, B.; Yuan, L.; Zhang, B.; Zhang, L.K.; Zhang, X.; Zhou, H.Y. Consensus of experts on information management of narcotic drugs and psychotropic drugs in medical institutions. Her. Med. 2022, 41, 1–7.

The opioid crisis in the United States and the strategies to address the epidemic

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 27

Related Articles 0

Recommended Articles

Metrics

Comments